IBDEI1RT ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29644,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,29645,0)
 ;;=E10.621^^135^1364^7
 ;;^UTILITY(U,$J,358.3,29645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29645,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,29645,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,29645,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,29646,0)
 ;;=E10.622^^135^1364^11
 ;;^UTILITY(U,$J,358.3,29646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29646,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,29646,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,29646,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,29647,0)
 ;;=E10.65^^135^1364^10
 ;;^UTILITY(U,$J,358.3,29647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29647,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,29647,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,29647,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,29648,0)
 ;;=E10.39^^135^1364^9
 ;;^UTILITY(U,$J,358.3,29648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29648,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,29648,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,29648,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,29649,0)
 ;;=E66.3^^135^1364^45
 ;;^UTILITY(U,$J,358.3,29649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29649,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,29649,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,29649,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,29650,0)
 ;;=E89.1^^135^1364^49
 ;;^UTILITY(U,$J,358.3,29650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29650,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,29650,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,29650,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,29651,0)
 ;;=H40.9^^135^1365^9
 ;;^UTILITY(U,$J,358.3,29651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29651,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,29651,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,29651,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,29652,0)
 ;;=H26.9^^135^1365^5
 ;;^UTILITY(U,$J,358.3,29652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29652,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,29652,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,29652,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,29653,0)
 ;;=H10.9^^135^1365^8
 ;;^UTILITY(U,$J,358.3,29653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29653,1,3,0)
 ;;=3^Conjunctivitis,Unspec
 ;;^UTILITY(U,$J,358.3,29653,1,4,0)
 ;;=4^H10.9
 ;;^UTILITY(U,$J,358.3,29653,2)
 ;;=^5004716
 ;;^UTILITY(U,$J,358.3,29654,0)
 ;;=H11.32^^135^1365^6
 ;;^UTILITY(U,$J,358.3,29654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29654,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,29654,1,4,0)
 ;;=4^H11.32
 ;;^UTILITY(U,$J,358.3,29654,2)
 ;;=^5004783
 ;;^UTILITY(U,$J,358.3,29655,0)
 ;;=H11.31^^135^1365^7
 ;;^UTILITY(U,$J,358.3,29655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29655,1,3,0)
 ;;=3^Conjunctival Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,29655,1,4,0)
 ;;=4^H11.31
 ;;^UTILITY(U,$J,358.3,29655,2)
 ;;=^5004782
 ;;^UTILITY(U,$J,358.3,29656,0)
 ;;=H01.002^^135^1365^3
 ;;^UTILITY(U,$J,358.3,29656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29656,1,3,0)
 ;;=3^Blepharitis Unspec,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,29656,1,4,0)
 ;;=4^H01.002
 ;;^UTILITY(U,$J,358.3,29656,2)
 ;;=^5004239
 ;;^UTILITY(U,$J,358.3,29657,0)
 ;;=H01.004^^135^1365^2
 ;;^UTILITY(U,$J,358.3,29657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,29657,1,3,0)
 ;;=3^Blepharitis Unspec,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,29657,1,4,0)
 ;;=4^H01.004
 ;;^UTILITY(U,$J,358.3,29657,2)
 ;;=^5004241
